Why the study?
Does antibody-induced platelet injury trigger intravascular clotting in rabbits?
Does antibody-induced platelet injury trigger intravascular clotting in rabbits?
Antibody-induced injury of the platelet membrane triggers moderate intravascular clotting in an animal model.
Answers are grounded in this paper and cite their sources.
Antibody-induced platelet injury may initiate clotting in rabbits; leaves open human relevance pending clinical studies.
Rabbits were injected with platelet antiserum to investigate whether antibody‐induced injury of platelets triggers intravascular clotting. More than 97 % of the circulating platelets were acutely removed, and profound thrombocytopenia persisted during an observation period of 6 hrs. The thrombocytopenic effect of platelet antiserum was associated with moderately increased consumption of 125 I‐fibrinogen and significant decreases in factors V and VIII, while the level of antigen reacting like fibrinogen (FR‐antigen) in serum did not increase. The antiserum produced a transient leucopenia, and the effects of platelet antiserum were therefore also evaluated in rabbits made severely leucopenic, but not thrombocytopenic, with nitrogen mustard. Similar results were obtained, indicating that the consumption of clotting factors did not result from leucocyte injury. Pretreatment with Thorotrast reduced rather than enhanced the clotting changes after platelet antiserum. In these animals non‐clottable degradation products of fibrinogen were found in serum. In neither group were fibrin thrombi observed in glomerular capillaries at autopsy. Our findings support the concept that antibody‐induced injury of the platelet membrane triggered moderate intravascular clotting in normal animals. Thorotrast modified the response probably in multiple ways.
No takes yet. Share an insight, caveat, or question.
Evensen et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: